News

The companies hope that these antibodies will improve their understanding of the pathways that carry information inside of cells and why these pathways sometimes malfunction to cause disease.

The study will investigate the addition of Zactima (generic name vandetanib) to pemetrexed as second line treatment for patients with locally advanced or metastatic non-small cell lung cancer

The collaboration will focus on Adnectin-based therapeutics. Adnectins are based on human fibronectin, an extracellular protein that is naturally abundant in human serum. Adnectins are designed using the

“While prostate cancer growth is driven by androgens like testosterone, current anti-androgen therapies do not stop the growth of hormone-refractory prostate tumors. “These preclinical findings with MDV3100 are

The study involved four groups of eight rats, each group receiving a different level of black soya in their diet. The group that received the highest level of

The trial is being conducted by Merck and its US affiliate EMD Pharmaceuticals pursuant to the terms of a collaboration. Merck obtained the exclusive worldwide licensing rights for

The safety and efficacy of Cymbalta in the treatment of generalized anxiety disorder (GAD) was established in three studies in non-depressed adults with GAD. In all studies, Cymbalta

The results demonstrated a major response rate of 24% with a median overall survival at follow up of 8.5 months and a median time to progression of 3.5

Cobble is director of Canyons Medical Center in Sandy, Utah. Cobble is a primary care physician, board-certified lipidologist and certified hypertension specialist. Cobble succeeds James Ehrlich, M.D., who